All Newron articles
-
Business
EU recommends Parkinson’s drug for approval
First new molecule for a decade, but Alzheimer’s still posing challenges as antibody treatment withdrawn from trials
First new molecule for a decade, but Alzheimer’s still posing challenges as antibody treatment withdrawn from trials